SLXNWSilexion Therapeutics Ltd.

0.0107USDMkt Cap: —P/E: —5d ago

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of sol…

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-11.91M $

Revenue/Share—

Last Price0.0107 USD

Fiscal Year End—

MR Quarter—

Employees13

CountryUS

Sector—

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.02

EPS (TTM)—

EPS (Forward)—

52W Range

0.01070% of range0.0150

52W High0.0150 USD

52W Low0.0107 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-457.63%

ROA-165.10%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-10.82M $

CapEx (TTM)9.00K $

FCF Margin—

FCF Yield—

Net Debt-424.00K $

Net Debt/EBITDA0.03

Balance Sheet

Debt/Equity0.78

Current Ratio1.00

Quick Ratio0.59

Book Value/Sh0.8570 USD

Cash/Share5.759 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float414.62K

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta-0.27

S&P 52W Chg21.00%

Avg Vol (30d)10.73K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—